RESUMO
Macrophages are key innate immune cells involved in multiple biological processes, including peripheral nerve regeneration. Here, we describe a protocol for the adoptive cell transfer of bone-marrow-derived macrophages (BMDMs) following sciatic nerve crush injury (SNCI). This procedure involves isolating BMDMs from a donor mouse, potentially manipulating them ex vivo, and reintroducing them into an animal following SNCI. Preclinical studies show that BMDMs can infiltrate injured nerves and impact functional recovery, potentially providing a novel therapy for nerve injuries. For complete details on the use and execution of this protocol, please refer to Jha et al.1.
Assuntos
Traumatismos dos Nervos Periféricos , Animais , Camundongos , Traumatismos dos Nervos Periféricos/terapia , Nervo Isquiático , Macrófagos , Regeneração Nervosa/fisiologia , Transferência AdotivaRESUMO
Metal-free porous activated carbon is an effective alternative to capture CO2 due to its high surface area and textural advantages. In this regard, the present research work explores a suitable method for producing activated porous carbon with a high specific surface area through a two-step reaction involving rice husk and KOH at 600 °C for 1 h to capture CO2. By varying the ratio of rice husk biomass to KOH, the texture and specific surface area of the activated porous carbon has been altered. A high surface area of â¼755 m2/g and a micropore volume of 0.243 cm3/g have been observed in the porous carbon produced with a KOH/biomass weight ratio of 3 (PAC2). Nitrogen contents in PAC1 and PAC2 were approximately 2.27 and 2.71 atom %, respectively. When compared with other materials, PAC2 has the highest CO2 adsorption capability, reaching up to 3.13 mmol/g at 0 °C and 1.55 mmol/g at 50 °C. The isosteric heat of adsorption confirms the presence of both physisorption and chemisorption. The materials turn out to be highly CO2/N2 selective, with the highest selectivity of 131, proving that the samples are potential materials for capturing CO2 from flue gases. These findings unequivocally show that porous activated carbon can be used to make CO2 adsorption efficient, inexpensive, and, more importantly, extremely effective.
RESUMO
Peripheral nerves have the capacity for regeneration, but the rate of regeneration is so slow that many nerve injuries lead to incomplete recovery and permanent disability for patients. Macrophages play a critical role in the peripheral nerve response to injury, contributing to both Wallerian degeneration and nerve regeneration, and their function has recently been shown to be dependent on intracellular metabolism. To date, the impact of their intracellular metabolism on peripheral nerve regeneration has not been studied. We examined conditional transgenic mice with selective ablation in macrophages of solute carrier family 16, member 1 (Slc16a1), which encodes monocarboxylate transporter 1 (MCT1), and found that MCT1 contributed to macrophage metabolism, phenotype, and function, specifically in regard to phagocytosis and peripheral nerve regeneration. Adoptive cell transfer of wild-type macrophages ameliorated the impaired nerve regeneration in macrophage-selective MCT1-null mice. We also developed a mouse model that overexpressed MCT1 in macrophages and found that peripheral nerves in these mice regenerated more rapidly than in control mice. Our study provides further evidence that MCT1 has an important biological role in macrophages and that manipulations of macrophage metabolism can enhance recovery from peripheral nerve injuries, for which there are currently no approved medical therapies.
Assuntos
Macrófagos/metabolismo , Transportadores de Ácidos Monocarboxílicos/metabolismo , Regeneração Nervosa , Traumatismos dos Nervos Periféricos/metabolismo , Nervo Isquiático , Simportadores/metabolismo , Animais , Feminino , Masculino , Camundongos , Camundongos Transgênicos , Transportadores de Ácidos Monocarboxílicos/genética , Traumatismos dos Nervos Periféricos/genética , Nervo Isquiático/lesões , Nervo Isquiático/fisiologia , Simportadores/genéticaRESUMO
Castor plant (Ricinus communis) is a fast-growing shrub from Euphorbiaceae family. India ranks first in the world for the production of castor seeds. The generation of residue from its leaves and stems is more than 50% of the whole plant. This research work involves the estimation of the optimum condition for the production/value addition by hydrothermal liquefaction of castor residue using factorial design. Temperature (T) and residence time (RT) are the key parameters that affect the bio-oil yield. A 32 full factorial design was employed to understand the affects the bio-oil yield and conversion with key parameters. The key parameter and its interaction effects were analyzed by analysis of variance (ANOVA); F-test and p-values were used to rank the process variable affecting the total bio-oil yield. It was observed that the temperature imparts significant effect on total bio-oil yield. The optimum conditions to obtain maximum total bio-oil yield are Tâ¯=â¯300⯰C and RTâ¯=â¯60â¯min. The statistical model was best fitted with high coefficient of determination (R2) of 0.9994 and 0.9473 for total bio-oil yield and conversion respectively.
Assuntos
Biocombustíveis , Óleos de Plantas , Polifenóis , Ricinus , Biomassa , Índia , TemperaturaRESUMO
GNF-2 is an allosteric inhibitor of Bcr-Abl. It was developed as a new class of anti-cancer drug to treat resistant chronic myelogenous leukemia. Recent studies suggest that c-Abl inhibition would provide a neuroprotective effect in animal models of Parkinson's disease as well as in clinical trials. However, the role of c-Abl and effects of GNF-2 in glia-mediated neuroinflammation or pain hypersensitivity has not been investigated. Thus, in the present study, we tested the hypothesis that c-Abl inhibition by GNF-2 may attenuate the inflammatory activation of glia and the ensuing pain behaviors in animal models. Our results show that GNF-2 reduced lipopolysaccharide (LPS)-induced nitric oxide and pro-inflammatory cytokine production in cultured glial cells in a c-Abl-dependent manner. The small interfering ribonucleic acid (siRNA)-mediated knockdown of c-Abl attenuated LPS-induced nuclear factor kappa light chain enhancer of activated B cell (NF-κB) activation and the production of pro-inflammatory mediators in glial cell cultures. Moreover, GNF-2 administration significantly attenuated mechanical and thermal hypersensitivities in experimental models of diabetic and inflammatory pain. Together, our findings suggest the involvement of c-Abl in neuroinflammation and pain pathogenesis and that GNF-2 can be used for the management of chronic pain.
RESUMO
Cryptococcosis is the opportunistic infection usually seen in immunocompromised individuals. Among human immunodeficiency virus (HIV)-seropositive participants, cryptococcal meningitis is the second most common cause of opportunistic neuro-infection, but at times, it occurs in non-HIV patients who are immunodeficient due to other reasons like chronic glucocorticoid use, organ transplantation, malignancy, and sarcoidosis and has rarely been described in diabetic patients. We present a fatal case of Cryptococcus gattii meningitis in a 56-year-old HIV-negative male patient with diabetes mellitus.
RESUMO
While glial activation is an integral part of pain pathogenesis, the existence of a causal relationship between glia and pain processing has yet to be demonstrated in vivo. Here, we have investigated whether the activation of spinal astrocytes could directly evoke pain hypersensitivity in vivo via the use of optogenetic techniques. Optogenetic stimulation of channelrhopdopsin-2 (ChR)-expressing spinal astrocytes induced pain hypersensitivity in a reversible and time-dependent manner, which was accompanied by glial activation, NR1 phosphorylation, ATP release, and the production of proalgesic mediators. Photostimulation of ChR2-expressing astrocytes in culture and spinal slices recapitulated in vivo findings, demonstrating the release of proalgesic mediators and electrophysiological disinhibition of spinal projection neurons. These findings deepen our understanding of the role of astrocytes in pain pathogenesis and provide the scientific basis for an astrocyte-oriented pain treatment.
Assuntos
Astrócitos/metabolismo , Hipersensibilidade/genética , Dor/genética , Rodopsina/genética , Trifosfato de Adenosina/metabolismo , Astrócitos/patologia , Regulação da Expressão Gênica , Humanos , Hipersensibilidade/fisiopatologia , Proteínas do Tecido Nervoso/genética , Neuroglia/metabolismo , Neuroglia/fisiologia , Neurônios/metabolismo , Neurônios/patologia , Optogenética , Dor/fisiopatologia , Medula Espinal/metabolismo , Medula Espinal/fisiopatologiaRESUMO
Pyruvate dehydrogenase kinases (PDK1-4) are mitochondrial metabolic regulators that serve as decision makers via modulation of pyruvate dehydrogenase (PDH) activity to convert pyruvate either aerobically to acetyl-CoA or anaerobically to lactate. Metabolic dysregulation and inflammatory processes are two sides of the same coin in several pathophysiological conditions. The lactic acid surge associated with the metabolic shift has been implicated in diverse painful states. In this study, we investigated the role of PDK-PDH-lactic acid axis in the pathogenesis of chronic inflammatory pain. Deficiency of Pdk2 and/or Pdk4 in mice attenuated complete Freund's adjuvant (CFA)-induced pain hypersensitivities. Likewise, Pdk2/4 deficiency attenuated the localized lactic acid surge along with hallmarks of peripheral and central inflammation following intraplantar administration of CFA. In vitro studies supported the role of PDK2/4 as promoters of classical proinflammatory activation of macrophages. Moreover, the pharmacological inhibition of PDKs or lactic acid production diminished CFA-induced inflammation and pain hypersensitivities. Thus, a PDK-PDH-lactic acid axis seems to mediate inflammation-driven chronic pain, establishing a connection between metabolism and inflammatory pain. SIGNIFICANCE STATEMENT: The mitochondrial pyruvate dehydrogenase (PDH) kinases (PDKs) and their substrate PDH orchestrate the conversion of pyruvate either aerobically to acetyl-CoA or anaerobically to lactate. Lactate, the predominant end product of glycolysis, has recently been identified as a signaling molecule for neuron-glia interactions and neuronal plasticity. Pathological metabolic shift and subsequent lactic acid production are thought to play an important role in diverse painful states; however, their contribution to inflammation-driven pain is still to be comprehended. Here, we report that the PDK-PDH-lactic acid axis constitutes a key component of inflammatory pain pathogenesis. Our findings establish an unanticipated link between metabolism and inflammatory pain. This study unlocks a previously ill-explored research avenue for the metabolic control of inflammatory pain pathogenesis.
Assuntos
Inflamação/complicações , Ácido Láctico/metabolismo , Dor/etiologia , Dor/metabolismo , Proteínas Serina-Treonina Quinases/deficiência , Complexo Piruvato Desidrogenase/metabolismo , Animais , Células Cultivadas , Modelos Animais de Doenças , Edema/etiologia , Edema/patologia , Regulação da Expressão Gênica/fisiologia , Hiperalgesia/fisiopatologia , Inflamação/congênito , Macrófagos/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Condução Nervosa/genética , Medição da Dor , Limiar da Dor/fisiologia , Proteínas Serina-Treonina Quinases/genética , Piruvato Desidrogenase Quinase de Transferência de Acetil , Fatores de TempoRESUMO
Lipocalin-2 (LCN2), a secretory protein, regulates diverse cellular processes such as cell death/survival, cell migration/invasion, cell differentiation, iron delivery, inflammation, insulin resistance, and tissue regeneration. Recently, we reported that LCN2 is secreted by brain astrocytes under inflammatory conditions and that it promotes apoptosis, morphological changes, and migration in astrocytes both in vitro and in vivo. Activated astrocytes release LCN2 not only to induce the morphological transformation associated with reactive astrocytosis, but also to promote their own death. Under inflammatory conditions, activated astrocytes also show functional dichotomy similar to the M1/M2 phenotypes of microglia and macrophages. LCN2 is thought to be a chemokine inducer and an autocrine promoter of the classical proinflammatory activation of astrocytes. This article summarizes the current knowledge regarding the role of astrocyte-derived LCN2 as a proinflammatory mediator in the central nervous system and discusses LCN2's role in neuroinflammatory disorders.
Assuntos
Proteínas de Fase Aguda/metabolismo , Astrócitos/imunologia , Encéfalo/imunologia , Lipocalinas/metabolismo , Doenças Neurodegenerativas/imunologia , Proteínas Proto-Oncogênicas/metabolismo , Proteínas de Fase Aguda/imunologia , Animais , Apoptose , Comunicação Autócrina , Humanos , Lipocalina-2 , Lipocalinas/imunologia , Inflamação Neurogênica , Proteínas Proto-Oncogênicas/imunologiaRESUMO
Lipocalin-2 (LCN2) is an acute phase protein induced in response to injury, infection or other inflammatory stimuli. Based on the previously reported involvement of LCN2 in chemokine induction and in the recruitment of neutrophils at the sites of infection or tissue injury, we investigated the role of LCN2 in the pathogenesis of chronic/persistent inflammatory pain hypersensitivity. In the complete Freund's adjuvant (CFA)-induced chronic inflammatory pain model, LCN2 expression was strongly induced in the ipsilateral hindpaws, peaking at 12h after CFA injection and then gradually subsiding. In CFA-injected hindpaw tissues, LCN2 and its receptor 24p3R were mainly expressed in infiltrating neutrophils and macrophages. CFA-induced thermal hyperalgesia and mechanical allodynia were significantly diminished in Lcn2-deficient mice compared to wild-type animals. Furthermore, neutrophil infiltration, myeloperoxidase activity, expression of TNF-α, IL-1ß and MIP-2 in CFA-injected hindpaws, and spinal glial activation were markedly reduced by Lcn2 deficiency. An intraplantar injection of recombinant LCN2 protein induced thermal and mechanical hypersensitivities in naïve mice, and this was accompanied by neutrophil and macrophage infiltration into the hindpaws and glial activation in the dorsal horn of the spinal cord. Taken together, our results show that inflammatory cell-derived LCN2 at the sites of inflammation plays important roles in central sensitization and the subsequent nociceptive behavior in the rodent model of chronic inflammatory pain.
Assuntos
Proteínas de Fase Aguda/imunologia , Dor Crônica/imunologia , Hiperalgesia/imunologia , Inflamação/imunologia , Lipocalinas/imunologia , Proteínas Oncogênicas/imunologia , Proteínas de Fase Aguda/genética , Proteínas de Fase Aguda/farmacologia , Adjuvantes Imunológicos/farmacologia , Animais , Células Cultivadas , Dor Crônica/genética , Citocinas/imunologia , Modelos Animais de Doenças , Feminino , Adjuvante de Freund/farmacologia , Hiperalgesia/genética , Inflamação/induzido quimicamente , Inflamação/genética , Lipocalina-2 , Lipocalinas/genética , Lipocalinas/farmacologia , Macrófagos Peritoneais/citologia , Macrófagos Peritoneais/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neutrófilos/citologia , Neutrófilos/imunologia , Nociceptores/imunologia , Proteínas Oncogênicas/genética , Proteínas Oncogênicas/farmacologia , Receptores de Superfície Celular/genética , Receptores de Superfície Celular/imunologia , Proteínas Recombinantes/farmacologia , Medula Espinal/imunologiaRESUMO
Lipocalin 2 (LCN2), which is also known as 24p3 and neutrophil gelatinase-associated lipocalin (NGAL), binds small, hydrophobic ligands and interacts with cell surface receptor 24p3R to regulate diverse cellular processes. In the present study, we examined the role of LCN2 in the pathogenesis of neuropathic pain using a mouse model of spared nerve injury (SNI). Lcn2 mRNA levels were significantly increased in the dorsal horn of the spinal cord after SNI, and LCN2 protein was mainly localized in neurons of the dorsal and ventral horns. LCN2 receptor 24p3R was expressed in spinal neurons and microglia after SNI. Lcn2-deficient mice exhibited significantly less mechanical pain hypersensitivity during the early phase after SNI, and an intrathecal injection of recombinant LCN2 protein elicited mechanical pain hypersensitivity in naive animals. Lcn2 deficiency, however, did not affect acute nociceptive pain. Lcn2-deficient mice showed significantly less microglial activation and proalgesic chemokine (CCL2 and CXCL1) production in the spinal cord after SNI than wild-type mice, and recombinant LCN2 protein induced the expression of these chemokines in cultured neurons. Furthermore, the expression of LCN2 and its receptor was detected in neutrophils and macrophages in the sciatic nerve following SNI, suggesting the potential role of peripheral LCN2 in neuropathic pain. Taken together, our results indicate that LCN2 plays a critical role in the development of pain hypersensitivity following peripheral nerve injury and suggest that LCN2 mediates neuropathic pain by inducing chemokine expression and subsequent microglial activation.
Assuntos
Proteínas de Fase Aguda/metabolismo , Quimiocinas/metabolismo , Lipocalinas/metabolismo , Neuralgia/etiologia , Neuralgia/metabolismo , Proteínas Oncogênicas/metabolismo , Traumatismos dos Nervos Periféricos/complicações , Traumatismos dos Nervos Periféricos/metabolismo , Transdução de Sinais , Proteínas de Fase Aguda/genética , Proteínas de Fase Aguda/farmacologia , Animais , Células Cultivadas , Córtex Cerebral/patologia , Quimiocinas/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Hiperalgesia/complicações , Hiperalgesia/metabolismo , Hiperalgesia/patologia , Lipocalina-2 , Lipocalinas/genética , Lipocalinas/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Microglia/efeitos dos fármacos , Microglia/enzimologia , Microglia/patologia , Modelos Biológicos , Neuralgia/enzimologia , Neuralgia/patologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Nociceptividade/efeitos dos fármacos , Proteínas Oncogênicas/genética , Proteínas Oncogênicas/farmacologia , Traumatismos dos Nervos Periféricos/enzimologia , Traumatismos dos Nervos Periféricos/patologia , Fosforilação/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores de Superfície Celular/metabolismo , Nervo Isquiático/efeitos dos fármacos , Nervo Isquiático/metabolismo , Nervo Isquiático/patologia , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Medula Espinal/efeitos dos fármacos , Medula Espinal/metabolismo , Medula Espinal/patologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismoRESUMO
Metabolic aberrations in the form of altered flux through key metabolic pathways are the major hallmarks of several life-threatening malignancies including malignant gliomas. These adaptations play an important role in the enhancement of the survival and proliferation of gliomas at the expense of the surrounding normal/healthy tissues. Recent studies in the field of neurooncology have directly targeted the altered metabolic pathways of malignant tumor cells for the development of anti-cancer drugs. Aerobic glycolysis due to elevated production of lactate from pyruvate regardless of oxygen availability is a common metabolic alteration in most malignancies. Aerobic glycolysis offers survival advantages in addition to generating substrates such as fatty acids, amino acids and nucleotides required for the rapid proliferation of cells. This review outlines the role of pyruvate dehydrogenase kinase (PDK) in gliomas as an inhibitor of pyruvate dehydrogenase that catalyzes the oxidative decarboxylation of pyruvate. An in-depth investigation on the key metabolic enzyme PDK may provide a novel therapeutic approach for the treatment of malignant gliomas.
RESUMO
NFAT and NF-kappaB proteins are members of a superfamily of transcription factors whose activity plays a crucial role in the activation, proliferation and apoptosis of lymphocytes. Both types of factors share a number of properties, including similar DNA binding domains and rapid nuclear translocation upon antigenic stimulation. While NF-kappaBs control both innate and adaptive immune responses, NFATs control the adaptive immune system which emerged-in parallel with the appearance of the NFAT family-in jawed fish. However, NFATs and NF-kappaBs differ remarkably in their function. Whereas NFATs support activation-induced cell death (AICD) of T and B cells, NF-kappaB proteins frequently exert a strong anti-apoptotic effect on lymphocytes and other cells. While the anti-apoptotic activity of NF-kappaBs contributes to their oncogenic capacity, the pro-apoptotic activity favors NFATs as tumor suppressors in lymphoid cells.
Assuntos
Proteínas de Ligação a DNA/fisiologia , NF-kappa B/fisiologia , Proteínas Nucleares/fisiologia , Fatores de Transcrição/fisiologia , Animais , Apoptose/fisiologia , Linfócitos B/fisiologia , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Humanos , Camundongos , NF-kappa B/genética , NF-kappa B/metabolismo , Fatores de Transcrição NFATC , Neoplasias/metabolismo , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Linfócitos T/fisiologia , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismoRESUMO
Treatment of Th cells with compounds that elevate cAMP levels augments Th2-type lymphokine expression, in particular the synthesis of IL-5. Using primary murine CD4(+) T lymphocytes, we show in this study that inhibition of protein kinase A (PKA) activity in Th2 effector cells impairs IL-5 synthesis, whereas the expression of PKA catalytic subunit alpha enhances IL-5 synthesis in Th0 cells. In addition, we observed by coexpression of PKA catalytic subunit and GATA-3 in Th1 cells that the stimulatory effect of PKA is dependent on GATA-3 activity. These data demonstrate that activation of PKA in Th effector cells induces the IL-5 gene expression in a GATA-3-dependent manner.
Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/fisiologia , Proteínas de Ligação a DNA/fisiologia , Regulação da Expressão Gênica/imunologia , Interleucina-5/biossíntese , Interleucina-5/genética , Sulfonamidas , Células Th2/imunologia , Células Th2/metabolismo , Transativadores/fisiologia , Animais , Domínio Catalítico/genética , Domínio Catalítico/imunologia , Linhagem Celular , Células Cultivadas , AMP Cíclico/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Proteínas Quinases Dependentes de AMP Cíclico/genética , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Inibidores Enzimáticos/farmacologia , Fator de Transcrição GATA3 , Humanos , Interleucina-4/biossíntese , Isoquinolinas/farmacologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Transgênicos , Mutação , Subunidades Proteicas/biossíntese , Subunidades Proteicas/genética , Células Th1/imunologia , Células Th1/metabolismo , Células Th2/enzimologia , Transfecção , Células Tumorais Cultivadas , Regulação para Cima/genética , Regulação para Cima/imunologiaRESUMO
Hematopoietic progenitor kinase 1 (HPK1) is a member of germinal center kinases that is predominantly expressed in hematopoietic cells and transiently activated by T-cell receptor (TCR) triggering. We show here that HPK1 supports apoptosis of T cells. When HPK1 was overexpressed in murine CD4(+) T cells, a substantial increase was observed in spontaneous and TCR/CD3-mediated apoptosis as well as in Fas ligand (FasL) expression. In H2O2-treated EL-4 thymoma cells, which show an increase in reactive oxygen species (ROS) and apoptosis, overexpression of HPK1 enhanced ROS-mediated apoptosis, whereas expression of HPK1 antisense (AS) RNA impaired apoptosis. HPK1 expression also led to a sustained increase in c-Jun N-terminal kinase (JNK) activity, suggesting that JNK activation contributes to the HPK1-mediated apoptosis in H2O2-treated EL-4 cells. Under the same conditions, a rapid cleavage of HPK1 was observed, and overexpression of N- and C-terminal cleavage products in CD4(+) T cells resulted in, similar to full-length HPK1, an increase in apoptosis. In agreement with published data, we show that the C-terminal portion of HPK1 suppresses IkappaBalpha degradation, thereby inhibiting nuclear factor (NF)-kappaB activation. These findings suggest that by inhibiting the antiapoptotic action of NF-kappaB and inducing the proapoptotic activity of JNK, OHPK1 supports apoptosis in T cells.